why choose us

First received: January 30, 2023

Clinical Trial: Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients With Glioblastoma

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Glioblastoma

Study Type: INTERVENTIONAL


Official Title: A Phase I De-Escalation Study of Dexamethasone With Azeliragon for Management of Post-Resection Cerebral Edema in Patients With Glioblastoma

Brief Summary: This phase I trial tests the safety, side effects, and best dose of dexamethasone when given with azeliragon in managing cerebral edema after surgery (post-resection) in patients with glioblastoma.Cerebral edema is a pathological increase in the water mass contained within the brain interstitial space.Dexamethasone is in a class of medications called corticosteroids.It is used to reduce inflammation and lower the body's immune response to help lessen the side effects of chemotherapy drugs.Azeliragon is an…

Read more